Share
CNBC Pro

Watch CNBC's full interview with Merck CEO Rob Davis on $11.5 billion Acceleron acquisition

Merck CEO Rob Davis joins CNBC's Meg Tirrell to discuss the company's major acquisition of Acceleron Pharma valued at $11.5 billion and provides an update on Merck's highly anticipated Covid-19 pill.
11:53
Thu, Sep 30 20217:35 AM EDT

watch now
VIDEO44:23
CNBC ProWatch Thursday's full episode of Fast Money — January 27, 2022
watch now
VIDEO09:57
CNBC ProTesla, Apple, and Intel are some of today's picks: Pro Market Movers Jan. 27
watch now
VIDEO44:55
CNBC ProWatch Thursday's full episode of the Halftime Report — January 27, 2022
watch now
VIDEO03:46
CNBC ProUnitedHealth, ARKK, and more: CNBC's 'Halftime Report' traders answer your questions
watch now
VIDEO03:28
CNBC ProWatch the full interview with Citi equity strategist Scott Chronert on volatility and looming rate hikes